Shifting the paradigm: engaging multicellular networks for cancer therapy
Abstract Most anti-cancer modalities are designed to directly kill cancer cells deploying mechanisms of action (MOAs) centered on the presence of a precise target on cancer cells. The efficacy of these approaches is limited because the rapidly evolving genetics of neoplasia swiftly circumvents the M...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Journal of Translational Medicine |
Online Access: | https://doi.org/10.1186/s12967-024-05043-8 |